Serum Amyloid A as an Independent Prognostic Factor for Renal Cell Carcinoma - A Hospital Based Study from the Western Region of Nepal |
Mittal, Ankush
(Department of Biochemistry, Nepalese Army Institute of Health Sciences, Manipal College of Medical Sciences)
Poudel, Bibek (Department of Biochemistry, Nepalese Army Institute of Health Sciences, Manipal College of Medical Sciences) Pandeya, Dipendra Raj (Department of Biochemistry, Nepalese Army Institute of Health Sciences, Manipal College of Medical Sciences) Gupta, Satrudhan Pd (Department of Biochemistry, Nepalese Army Institute of Health Sciences, Manipal College of Medical Sciences) Sathian, Brijesh (Department of Community Medicine, Nepalese Army Institute of Health Sciences, Manipal College of Medical Sciences) Yadav, Shambhu Kumar (Department of Biochemistry, Nepalese Army Institute of Health Sciences, Manipal College of Medical Sciences) |
1 | Johnson TV, DeLong J, Master VA (2012). C-reactive protein: a clinically useful biomarker in renal cell carcinoma. JAAPA, 25, 45-7. |
2 | Kimura M, Tomita Y, Imai T, et al (2001). Significance of serum amyloid a on the prognosis in patients with renal cell carcinoma. Cancer, 92, 2072-5. DOI |
3 | Kisilevsky R, Manley PN (2012). Acute-phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid, 19, 5-14. |
4 | Luke C, Sargent N, Pittman K, et al (2011). Epidemiology of cancers of the kidney in an Australian population. Asian Pac J Cancer Prev, 12, 2893-9. |
5 | Malle E, Sodin-Semrl S, Kovacevic A (2009). Serum amyloid A: an acutephase protein involved in tumour pathogenesis. Cell Mol Life Sci, 66, 9-26 DOI |
6 | Mohan S, Mohanasenthil, Paul SF, et al (2009). Interleukin-4- receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. APJCP, 10, 295-8. |
7 | Paret C, Scho¨n Z, Szponar A, et al (2010). Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome. Eur Urol, 57, 859-66. DOI |
8 | Singam P, Ho C, Hong GE, et al (2010). Clinical characteristics of renal cancer in Malaysia: a ten year review. Asian Pac J Cancer Prev, 11, 503-6. |
9 | Wood SL, Rogers M, Cairns DA, et al (2010). Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer. Br J Cancer, 103, 101-11. DOI |
10 | Chambers RE, Whicher JT (1983). Quantitative radial immunodiffusion assay for serum amyloid A protein. J Immunol Methods, 59, 95-103. DOI |
11 | Eichelberg C, Junker K, Ljungberg B, et al (2009). Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol, 55, 851-63. DOI |
12 | Fischer K, Theil G, Hoda R, et al (2012). Serum amyloid a: a biomarker for renal cancer. Anticancer Res, 32, 1801-4. |
13 | Johnson TV, Ali S, Abbasi A, et al (2011). Intra tumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. J Urol, 186, 1213-7. DOI |